Hans‐Reinhard Zerkowski is Chairman of Medtentia’s Clinical Advisory Board and an emeritus Professor of Cardiothoracic Surgery. He is actively involved in the development of CathHELIX®.
Prof. Zerkowski was former President of the Board of Genolier SMN SA (Swiss stock exchange; now AEVIS SA), the second largest hospital group in Switzerland. He was active in cardiothoracic surgery for over 30 years and also held roles in hospital leadership, management of research groups, guideline commissions, political committees, medical professional associations and non-profit organizations.
In 1994, he began his professorship of surgery as Surgeon-in-Chief and Head of Cardiothoracic Surgery (Chair) at Martin-Luther-University Halle-Wittenberg, Germany. In 1998, Prof. Zerkowski moved as a fully qualified Professor of Cardiothoracic Surgery (Chair) and Surgeon-in-Chief to the University Hospital Basel, Switzerland, and became Chairman of the Department of Surgery.
In addition to his extensive clinical experience (with more than 7,500 surgeries) and vast basic research expertise, he served as President of the German Cardiothoracic Society’s Guidelines Committee for almost seven years since its inception, as well as a member of the AZQ in Berlin (National Guidelines).
In 1985, he received the Ernst Derra Award from the German Association for Cardiac, Thoracic and Cardiovascular Surgery.
Prof. Zerkowski has been involved throughout his career in improving the treatment of valve disease. This includes the FDA approval of the ATS valve (1994-2007), especially in the mitral position (2005).